Identification of compounds that bind mitochondrial F1F0 ATPase by screening a triazine library for correction of albinism

Chemistry and Biology

Volumn 11, Issue 9, 2004, Pages 1251-1259

  Williams, Darren ^a   Jung, Da Woon ^b   Khersonsky, Sonya M ^b   Heidary, Noushin ^a   Chang, Young Tae ^b   Orlow, Seth J ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUROVERTIN; AUROVERTIN B; ENZYME INHIBITOR; MELANIN; MONOPHENOL MONOOXYGENASE; OLIGOMYCIN; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATASE; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; TRIAZINE DERIVATIVE;

ANIMAL; ARTICLE; C57BL MOUSE; CELL MEMBRANE POTENTIAL; CHEMICAL STRUCTURE; COMBINATORIAL CHEMISTRY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; IMMUNOHISTOCHEMISTRY; MELANOCYTE; METABOLISM; MITOCHONDRION; MOUSE; OCULAR ALBINISM; PIGMENTATION;

ALBINISM, OCULOCUTANEOUS; ANIMALS; AUROVERTINS; COMBINATORIAL CHEMISTRY TECHNIQUES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; IMMUNOHISTOCHEMISTRY; MELANINS; MELANOCYTES; MEMBRANE POTENTIALS; MICE; MICE, INBRED C57BL; MITOCHONDRIA; MITOCHONDRIAL PROTON-TRANSLOCATING ATPASES; MOLECULAR STRUCTURE; MONOPHENOL MONOOXYGENASE; OLIGOMYCINS; PIGMENTATION; PROTON-TRANSLOCATING ATPASES; TRIAZINES;

MURINAE;

EID: 4644307268     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2004.06.013     Document Type: Article

References (31)

1. Rinchik E.M., Bultman S.J., Horsthemke B., Lee S.T., Strunk K.M., Spritz R.A., Avidano K.M., Jong M.T., Nicholls R.D. A gene for the mouse pink-eyed dilution locus and for human type II oculocutaneous albinism. Nature. 361:1993;72-76
2. King R.A., Lewis R.A., Townsend D., Zelickson A., Olds D.P., Brumbaugh J. Brown oculocutaneous albinism. Clinical, ophthalmological, and biochemical characterization. Ophthalmology. 92:1985;1496-1505
3. Chen K., Manga P., Orlow S. Pink-eyed dilution protein controls the processing of tyrosinase. Mol. Biol Cell. 13:2002;1953-1964
4. Toyofuku K., Valencia J.C., Kushimoto T., Costin G.E., Virador V.M., Vieira W.D., Ferrans V.J., Hearing V.J. The etiology of oculocutaneous albinism (OCA) type II. the pink protein modulates the processing and transport of tyrosinase Pigment Cell Res. 15:2002;217-224
5. Manga P., Boissy R.E., Pifko-Hirst S., Zhou B.K., Orlow S.J. Mislocalization of melanosomal proteins in melanocytes from mice with oculocutaneous albinism type 2. Exp. Eye Res. 72:2001;695-710
6. Chen K., Minwalla L., Ni L., Orlow S.J. Correction of defective early tyrosinase processing by bafilomycin A1 and monensin in pink-eyed dilution melanocytes. Pigment Cell Res. 17:2004;36-42
7. Gray N.S. Combinatorial libraries and biological discovery. Curr. Opin. Neurobiol. 11:2001;608-614
8. Lokey R.S. Forward chemical genetics. progress and obstacles on the path to a new pharmacopoeia Curr. Opin. Chem. Biol. 7:2003;91-96
9. Mitsopoulos G., Walsh D.P., Chang Y.T. Tagged library approach to chemical genomics and proteomics. Curr. Opin. Chem. Biol. 8:2004;26-32
10. Schreiber S.L. Chemical genetics resulting from a passion of synthetic organic chemistry. Bioorg. Med. Chem. 6:1998;1127-1152
11. Schreiber S.L. The small-molecule approach to biology. Chem. Eng. News. 81:2003;51-61
12. Tan D.S. Sweet surrender to chemical genetics. Nat. Biotechnol. 20:2002;561-563
13. Ward G.E., Carey K.L., Westwood N.J. Using small molecules to study big questions in cellular microbiology. Cell. Microbiol. 4:2002;471-482
14. Jung G. Combinatorial Chemistry. Synthesis, Analysis, Screening:1999;Wiley-VCH, Cambridge
15. Miertus S., Fassina G. Combinatorial Chemistry and Technology. Principles, Methods, and Applications. 1999;Marcel Dekker, New York
16. Nicolaou K.C., Hanko R., Hartwig W. Handbook of Combinatorial Chemistry. Drugs, Catalysts, Materials:2002;Wiley-VCH, Weinheim
17. Seneci P. Solid-Phase Synthesis and Combinatorial Technologies. 2000;John Wiley & Sons, New York
18. Baraldi P.G., Cacciari B., Romagnoli R., Spalluto G., Monopoli A., Ongini E., Varani K., Borea P.A. 7-substituted 5-amino-2-(2-furyl)pyrazolo[4,3-e]-1,2, 4-triazolo[1,5-c]pyrimidines as A2A adenosine receptor antagonists. a study on the importance of modifications at the side chain on the activity and solubility J. Med. Chem. 45:2002;115-126
19. Chang Y.T., Gray N.S., Rosania G.R., Sutherlin D.P., Kwon S., Norman T.C., Sarohia R., Leost M., Meijer L., Schultz P.G. Synthesis and application of functionally diverse 2,6,9-trisubstituted purine libraries as CDK inhibitors. Chem. Biol. 6:1999;361-375
20. Chang Y.T., Choi G., Bae Y.S., Burdett M., Moon H.S., Lee J.W., Gray N.S., Schultz P.G., Meijer L., Chung S.K., et al. Purine-based inhibitors of inositol-1,4,5-trisphosphate-3-kinase. Chembiochem. 3:2002;897-901
21. Gangjee A., Yu J., Kisliuk R.L., Haile W.H., Sobrero G., McGuire J.J. Design, synthesis, and biological activities of classical N-[4-[2-(2-amino-4- ethylpyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-l-glutamic acid and its 6-methyl derivative as potential dual inhibitors of thymidylate synthase and dihydrofolate reductase and as potential antitumor agents. J. Med. Chem. 46:2003;591-600
22. Verdugo D.E., Cancilla M.T., Ge X., Gray N.S., Chang Y.T., Schultz P.G., Negishi M., Leary J.A., Bertozzi C.R. Discovery of estrogen sulfotransferase inhibitors from a purine library screen. J. Med. Chem. 44:2001;2683-2686
23. Drose S., Altendorf A.K. Bafilomycins and concanamycins as inhibitors of V-ATPases and P-ATPases. J. Exp. Biol. 200:1997;1-8
24. Halaban R., Patton R.S., Cheng E., Svedine S., Trombetta E.S., Wahl M.L., Ariyan S., Hebert D.N. Abnormal acidification of melanoma cells induces tyrosinase retention in the early secretory pathway. J. Biol. Chem. 277:2002;14821-14828
25. Dinter A., Berger B.E. Golgi-disturbing agents. Histochem. Cell. Biol. 109:1998;571-590
26. Ancans J., Hoogduijn M.J., Thody A.J. Melanosomal pH, pink locus protein and their roles in melanogenesis. J. Invest. Dermatol. 117:2001;158-159
27. Ernster L. Molecular Mechanism in Bioenergetics. 1992;Elsevier, Amsterdam
28. van Raaij M.J., Abrahams J.P., Leslie A.G., Walker J.E. The structure of bovine F1-ATPase complexed with the antibiotic inhibitor aurovertin B. Proc. Natl. Acad. Sci. USA. 93:1996;6913-6917
29. Khersonsky S.M., Jung D.W., Kang T.W., Walsh D.P., Moon H.S., Jo H., Jacobson E.M., Shetty V., Neubert T.A., Chang Y.T. Facilitated forward chemical genetics using a tagged triazine library and zebrafish embryo screening. J. Am. Chem. Soc. 125:2003;11804-11805
30. Sviderskaya E.V., Bennett D.C., Ho L., Bailin T., Lee S.T., Spritz R.A. Complementation of hypopigmentation in p-mutant (pink-eyed dilution) mouse melanocytes by normal human p cDNA, and defective complementation by OCA2 mutant sequences. J. Invest. Dermatol. 108:1997;30-34
31. Shen B., Rosenberg B., Orlow S.J. Intracellular distribution and late endosomal effects of the ocular albinism type 1 gene product. consequences of disease-causing mutations and implications for melanosome biogenesis Traffic. 2:2001;202-211